Long-term outcome and predictors of long-term disease activity in natalizumab-treated patients with multiple sclerosis: real life data from the Austrian MS Treatment Registry

被引：0
作者：
Michael Guger
Christian Enzinger
Fritz Leutmezer
Franziska Di Pauli
Jörg Kraus
Stefan Kalcher
Erich Kvas
Thomas Berger
机构：
[1] Kepler University Hospital GmbH,Clinic for Neurology 2, Med Campus III
[2] Johannes Kepler University Linz,Medical Faculty
[3] Medical University of Graz,Department of Neurology
[4] Medical University of Vienna,Department of Neurology
[5] Medical University of Innsbruck,Clinical Department of Neurology
[6] Paracelsus Medical University and Salzburger Landeskliniken,Department of Laboratory Medicine
[7] Heinrich-Heine-University,Department of Neurology, Medical Faculty
[8] Hermesoft,undefined
[9] Data management,undefined
[10] Hermesoft,undefined
[11] Statistics,undefined
来源：
Journal of Neurology | 2021年 / 268卷
关键词：
Disability progression; Long-term; Multiple sclerosis; Natalizumab; Predictor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4303 / 4310
页数：7
相关论文
共 69 条
[41]  
Phan-Ba A(undefined)undefined undefined undefined undefined-undefined
[42]  
Bartholome M(undefined)undefined undefined undefined undefined-undefined
[43]  
Evdoshenko M(undefined)undefined undefined undefined undefined-undefined
[44]  
Stepanova C(undefined)undefined undefined undefined undefined-undefined
[45]  
Shumilina F(undefined)undefined undefined undefined undefined-undefined
[46]  
Guger M(undefined)undefined undefined undefined undefined-undefined
[47]  
Enzinger C(undefined)undefined undefined undefined undefined-undefined
[48]  
Leutmezer F(undefined)undefined undefined undefined undefined-undefined
[49]  
Guger M(undefined)undefined undefined undefined undefined-undefined
[50]  
Enzinger C(undefined)undefined undefined undefined undefined-undefined
1234567